Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07696390

The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients diagnosed with myocardial infarction and admitted to the cardiology intensive care unit.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

SBU Van Training and Research Hospital

Van, 65, Turkey (Türkiye)

Location status: Recruiting

About this study

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients with myocardial infarction (MI) admitted to the cardiology intensive care unit. Studies examining the psychological (anxiety) and physiological (vital signs) effects of VR application on MI patients in cardiology intensive care units are quite limited. In this context, this study aims to examine the effects of VR glasses application on the vital signs (blood pressure, heart rate, SPO2, respiratory rate) and anxiety levels of MI patients in intensive care, within the framework of a randomized experimental design. The data obtained are expected to make significant contributions to the integration of technological interventions into cardiovascular disease management.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient is in intensive care.
  • The patient has been diagnosed with myocardial infarction.
  • The patient is between 18 and 70 years old.
  • The patient is conscious.
  • The patient is oriented and cooperative.
  • The patient volunteers to participate in the study.
  • The patient is open to communication.
  • The patient agrees to participate in the study.
  • The patient has no mental, visual, auditory, or speech impairment.
  • The patient has undergone stent placement.
  • The patient has STEMI.

Exclusion criteria

  • The patient has a psychiatric disorder.
  • The patient has any communication impairment.

Treatment and study plan

Virtual reality glasses

Other

Participants will be shown a video with nature images through virtual reality glasses, and their vital signs and anxiety levels will be measured.

Primary outcomes

  1. Anxiety Level

    Time frame: Periprocedural

    The patient's anxiety level will be measured using the State Anxiety Scale (STAI Form TX-1).

  2. Vital Signs - Blood pressure measurements (SBP, DBP)

    Time frame: Periprocedural

    Blood pressure measurements (SBP, DBP)

  3. Vital Signs- heart rate

    Time frame: Periprocedural

    heart rate will be taken.

  4. Vital Signs - respiratory rate per minute

    Time frame: Periprocedural

    respiratory rate per minute will be taken.

Study contacts

Contact information is provided by the study sponsor or research team.

Ayşe Özturk, MSc student

CONTACT

[email protected]

+905395934634

Yavuz Uren, Asst.Prof.

CONTACT

[email protected]

+905065961050

Sponsors and collaborators

Lead sponsor

Yuzuncu Yil University

Other

Registry information

Official study title

The Effect of Virtual Reality on Vital Signs and Anxiety in Myocardial Infarction Patients Admitted to Cardiology Intensive Care Unit: A Randomized Controlled Study.

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 10, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.